Furthermore, bidirectional signaling between macrophages and cancer cells involving CCR2 and CX3CR1 has been identified as a key mechanism driving lung cancer progression, highlighting the broader immunological relevance of this axis beyond T cell activity [50]. This evidence concerns the gene CCR2 and cancer.